Упрощенная HTML-версия
375.
Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in
Communities (ARIC) Study / A.R.
et al.] //
– 1998. –
Vol.16, № 11. – Р.1579-1583.
376.
Plasma fibrinogen and ischaemic heart disease risk factors / L. Moller [et al.] //
Arterioscler. Thromb. – 1991. – Vol.11. – Р.344-350.
377.
Plasma fibrinogen: levels and corelates in young adults / Folsom A.R. [et al.] //
Am. J. Epidemiol. – 1993. – Vol.138. – Р.1023-1036.
378.
Plasma leptin and insulin relationships in obese and nonobese humans / A.
Dagogo-Jack [et al.] // Diabetes. – 1998. – Vol. 45. - Р. 695-698.
379.
Plasma leptin levels in healthy children and adolescents: dependence on body
mass index, body fat mass, gender, pubertal stage, and testosterone / W. F.
Blum [et al.] // J Clin Endocrinol Metab. – 1997. – Vol. 82. – P. 2904-2910.
380.
Plasma soluble adhesion molecule and the progression of coronary
atherosclerosis / H. Yamamoto [et al.] // Eur. Heart J. – 1997. – Vol. 18
(Suppl.). – P. 48.
381.
Plasminogen activator inhibitor 1 in plasma: risk factor for recurrent
myocardial infarction / A. Hamsten [et al.] // Lancet. – 1987. – Vol. 2. – P. 3-8.
382.
Platelet aggregation in young men with contrasting predisposition to high
blood pressure / M. E. C. Dockrell [et al.] // Am. J. Hypertens. – 1999. – Vol.
12. – P. 115-119.
383.
Platelet aggregation patterns in normotensive and hypertensive subjects / S.
Gupta [et al.] // Indian J. Physiol. Pharmacol. – 2002. – № 46. – P. 379-382.
384.
Poulsen A. Psychodinamic, time-limited group therapy in rheumatic disease –
a controlled study with special reference to alexitimia / A. Poulsen //
Psychoter. Psychosom. –1991. – Vol. 56. – Р. 12-23.
385.
Prevalence and determinants of undertreatment of hypertension in the
Netherlands / H.
J. Hum. Hypertens. – 2004. – Vol. 18,
№ 5. – Р.317-324.